Jatenzo

DRUG2 trials

Sponsors

University of Miami, Tolmar Inc.

Conditions

HypogonadismTestosterone Deficiency

Phase 4

Patient Satisfaction After Switching to Oral Testosterone Undecanoate

CompletedNCT04983940

University of MiamiTestosterone Deficiency

Start: 2021-06-18End: 2023-04-06Updated: 2023-12-14

A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 Months

Active, not recruitingNCT06385509

Tolmar Inc.Hypogonadism

Start: 2024-05-10End: 2026-03-31Updated: 2025-09-04

Related Papers

MP35-14 PATIENT SATISFACTION AFTER SWITCHING TO ORAL TESTOSTERONE UNDECANOATE IN MEN CURRENTLY RECEIVING TESTOSTERONE THERAPY: AN OPEN-LABEL SINGLE-CENTER PHASE IV CLINICAL TRIAL

The Journal of Urology2022-04-071 citations